メンズヘルス診断市場：製品タイプ別、適応症別、エンドユーザー別-2025-2030年の世界予測

メンズヘルス診断市場は、2023年に131億7,000万米ドルと評価され、2024年には145億9,000万米ドルに達すると予測され、CAGR 11.31％で成長し、2030年には278億9,000万米ドルに達すると予測されています。

男性の健康診断市場には、心血管疾患、前立腺がん、テストステロン低下、糖尿病など、男性集団に蔓延する一般的な健康問題の特定、モニタリング、管理を目的としたさまざまな診断ツールやサービスが含まれます。これらの診断ソリューションには、高度な画像技術、バイオマーカー検査、遺伝子スクリーニング、ラボ検査、ポイントオブケア診断などが含まれます。男性の健康問題に対する意識が高まるにつれ、これらの診断は予防医療や正確な治療アプローチに不可欠なものとなっています。その用途は病院、診断センター、診療所、家庭など多岐にわたり、定期的なモニタリングと早期発見を可能にし、患者の転帰を改善するために極めて重要です。この市場は、男性特有の疾病の増加、健康意識の高まり、技術の進歩、革新的な診断方法などが主な要因となっています。最近の動向としては、診断精度を高めるためのAIと診断ツールの統合、非侵襲的検査法の開発、個々のニーズに対応するための個別化ヘルスケアソリューションなどが挙げられます。さらに、遠隔医療と遠隔診断は、デジタルヘルス導入の増加に牽引され、実質的な成長の道を示しています。しかし、新興国市場では診断検査費用の高騰、認識不足、ヘルスケアインフラの未整備などの課題に直面しており、市場拡大の妨げになる可能性があります。また、診断検査に関する厳しい規制や償還の問題も大きな障害となっています。イノベーションの機会は、費用対効果の高い診断ソリューションの開発、検査法の精度とアクセシビリティの向上、ハイテク企業とヘルスケアプロバイダーとのパートナーシップの醸成にあります。バイオマーカーの発見、AIを活用した診断、遠隔医療技術の強化などが調査の焦点となると思われます。男性の健康診断市場はダイナミックに進化しており、精密医療と早期発見に重点が置かれているため、男性の健康に対する全体的なアプローチを促進する技術とサービスへの戦略的投資の必要性が強調されています。アクセシビリティ、効率性、個別ケアに重点を置く企業は、この進化する市場環境で大きな報酬を得ることができます。

市場力学：急速に進化するメンズヘルス診断市場の主要市場インサイトを公開

メンズヘルス診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 不健康な食習慣と喫煙人口の増加
  • 生活習慣病の増加
  • 世界中の診断センター数の増加
• 市場抑制要因
  • 医療サービスの偏在
  • 限られた保険適用範囲と規制遵守
• 市場機会
  • ヘルスケアシステム強化に向けた政府の積極的な取り組み
  • 診断におけるIoTやAIなどの革新的技術の統合
• 市場の課題
  • 熟練した経験豊富な人材の不足

ポーターの5つの力：メンズヘルス診断市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：メンズヘルス診断市場における外部からの影響の把握

外部マクロ環境要因は、メンズヘルス診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析メンズヘルス診断市場における競合情勢の把握

メンズヘルス診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスメンズヘルス診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、メンズヘルス診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨メンズヘルス診断市場における成功への道筋を描く

メンズヘルス診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 不健康な食習慣と喫煙者の増加
    • 生活習慣病の発症率の増加
    • 世界中で診断センターの数が増加している
  • 抑制要因
    • 医療サービスの不均等な分配
    • 限定的な保険適用範囲と規制遵守
  • 機会
    • ヘルスケア制度強化に向けた政府の好ましい取り組み
    • 診断におけるIoTやAIなどの革新的技術の統合
  • 課題
    • 熟練した経験豊富な労働力の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 メンズヘルス診断市場：製品別

• 血液検査
• 心電図
• 前立腺のMRI
• テストステロンレベル検査
• 超音波検査
• 超音波ガイド下前立腺生検
• 尿道造影検査
• 尿検査
• X線

第7章 メンズヘルス診断市場タイプまたは適応症別

• 大腸がん
• 勃起不全
• 前立腺がん
• 精巣がん

第8章 メンズヘルス診断市場：エンドユーザー別

• 診断検査室
• 病院と外来手術センター
• 調査・学術機関

第9章 南北アメリカのメンズヘルス診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のメンズヘルス診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのメンズヘルス診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Access Pharmaceuticals, Inc.
• ADVANZ PHARMA Corp Limited
• Beckman Coulter, Inc.
• Bruker Corporation
• Cardinal Health Inc.
• Ecotown Diagnostics Pvt. Ltd.
• F. Hoffmann-La Roche Ltd.
• Future Diagnostics Solutions B.V.
• Medical Diagnosis
• Neuberg Diagnostics
• Nuance Communications, Inc.
• Pathnostics
• PERSOWN, INC.
• Quest Diagnostics Incorporated
• SEKISUI DIAGNOSTICS, LLC

LIST OF FIGURES

• FIGURE 1. MENS HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. MENS HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MENS HEALTH DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 154. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Mens Health Diagnostics Market was valued at USD 13.17 billion in 2023, expected to reach USD 14.59 billion in 2024, and is projected to grow at a CAGR of 11.31%, to USD 27.89 billion by 2030.

The men's health diagnostics market entails various diagnostic tools and services aimed at identifying, monitoring, and managing common health issues prevalent among male populations, such as cardiovascular diseases, prostate cancer, low testosterone, diabetes, and other conditions. These diagnostic solutions encompass advanced imaging techniques, biomarker tests, genetic screening, lab tests, and point-of-care diagnostics. As awareness of men's health issues grows, these diagnostics are essential for preventive health care and accurate treatment approaches. Their application spans hospitals, diagnostic centers, clinics, and home settings, enabling regular monitoring and early detection, which are crucial for improving patient outcomes. The market is predominantly driven by increasing incidences of male-specific diseases, rising health consciousness, advancements in technology, and innovative diagnostic methods. Recent opportunities rest in integrating AI with diagnostic tools for enhanced accuracy, the development of non-invasive testing methods, and personalized healthcare solutions to cater to individual needs. Additionally, telemedicine and remote diagnostics present substantial growth avenues, driven by increased digital health adoption. However, the market faces challenges, including high costs of diagnostic tests, lack of awareness, and inadequate healthcare infrastructure in developing regions, which might hinder market expansion. Stringent regulations related to diagnostic tests and reimbursement issues also pose significant obstacles. Innovation opportunities lie in developing cost-effective diagnostic solutions, improving the accuracy and accessibility of testing methods, and fostering partnerships between tech companies and healthcare providers. Research could focus on biomarker discovery, AI-driven diagnostics, and enhancing telehealth technologies. The men's health diagnostics market is dynamic and evolving, with an emphasis on precision medicine and early detection, emphasizing the need for strategic investments in technology and services that promote a holistic approach to men's health. Companies focusing on accessibility, efficiency, and personalized care stand to reap significant rewards in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mens Health Diagnostics Market

The Mens Health Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Unhealthy eating habits and growing prevalence of smoking population
  • Increased incidence of lifestyle disease
  • Rise in number of diagnostic centers all over the globe
• Market Restraints
  • Uneven distribution of medical services
  • Limited insurance coverage and regulatory compliance
• Market Opportunities
  • Favorable government initiatives to strengthen healthcare system
  • Integration of innovative technologies such as IoT and AI in diagnostic
• Market Challenges
  • Shortage of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Mens Health Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mens Health Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mens Health Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mens Health Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mens Health Diagnostics Market

A detailed market share analysis in the Mens Health Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mens Health Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mens Health Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mens Health Diagnostics Market

A strategic analysis of the Mens Health Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mens Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Access Pharmaceuticals, Inc., ADVANZ PHARMA Corp Limited, Beckman Coulter, Inc., Bruker Corporation, Cardinal Health Inc., Ecotown Diagnostics Pvt. Ltd., F. Hoffmann-La Roche Ltd., Future Diagnostics Solutions B.V., Medical Diagnosis, Neuberg Diagnostics, Nuance Communications, Inc., Pathnostics, PERSOWN, INC., Quest Diagnostics Incorporated, and SEKISUI DIAGNOSTICS, LLC.

Market Segmentation & Coverage

This research report categorizes the Mens Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Test, Electrocardiogram, MRI of the Prostate, Testosterone Levels Test, Ultrasound Test, Ultrasound-Guided Prostate Biopsy, Urethrogram, Urine Tests, and X-Ray.
• Based on Type or Indication, market is studied across Colorectal Cancer, Erectile Dysfunction, Prostate Cancer, and Testicular cancer.
• Based on End-user, market is studied across Diagnostic Laboratories, Hospitals & Ambulatory Surgery Center, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Unhealthy eating habits and growing prevalence of smoking population
    • 5.1.1.2. Increased incidence of lifestyle disease
    • 5.1.1.3. Rise in number of diagnostic centers all over the globe
  • 5.1.2. Restraints
    • 5.1.2.1. Uneven distribution of medical services
    • 5.1.2.2. Limited insurance coverage and regulatory compliance
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable government initiatives to strengthen healthcare system
    • 5.1.3.2. Integration of innovative technologies such as IoT and AI in diagnostic
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of skilled and experienced workforce
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Mens Health Diagnostics Market, by Product

• 6.1. Introduction
• 6.2. Blood Test
• 6.3. Electrocardiogram
• 6.4. MRI of the Prostate
• 6.5. Testosterone Levels Test
• 6.6. Ultrasound Test
• 6.7. Ultrasound-Guided Prostate Biopsy
• 6.8. Urethrogram
• 6.9. Urine Tests
• 6.10. X-Ray

7. Mens Health Diagnostics Market, by Type or Indication

• 7.1. Introduction
• 7.2. Colorectal Cancer
• 7.3. Erectile Dysfunction
• 7.4. Prostate Cancer
• 7.5. Testicular cancer

8. Mens Health Diagnostics Market, by End-user

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospitals & Ambulatory Surgery Center
• 8.4. Research & Academic Institutes

9. Americas Mens Health Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Mens Health Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Mens Health Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Access Pharmaceuticals, Inc.
• 2. ADVANZ PHARMA Corp Limited
• 3. Beckman Coulter, Inc.
• 4. Bruker Corporation
• 5. Cardinal Health Inc.
• 6. Ecotown Diagnostics Pvt. Ltd.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Future Diagnostics Solutions B.V.
• 9. Medical Diagnosis
• 10. Neuberg Diagnostics
• 11. Nuance Communications, Inc.
• 12. Pathnostics
• 13. PERSOWN, INC.
• 14. Quest Diagnostics Incorporated
• 15. SEKISUI DIAGNOSTICS, LLC